DOSE OF REALITY: LIST PRICE TRANSPARENCY WILL HELP HOLD BIG PHARMA ACCOUNTABLE AND LOWER PRESCRIPTION DRUG PRICES FOR PATIENTS
Congress Should Advance Bipartisan, Market-Based Measures to Increase… Read More

Congress Should Advance Bipartisan, Market-Based Measures to Increase… Read More
ICER Analysis of Leqembi Finds $26,500 Price Tag Exceeds Drug’s “Cost… Read More
Senate HELP Committee to Question Moderna CEO on Nearly 500 Percent Price Hike… Read More
Lawmakers Should Focus Attention on Brand Name Drug Companies That Set Prices,… Read More
Critical Legislation Targets Anti-Competitive Practices like Patent Thickets… Read More
New Matrix Global Advisors Report Shines Light on Cost of Big Pharma’s… Read More
Get the Facts on Big Pharma’s Year of Out-of-Control Launch Prices… Read More
JAMA Analysis Finds No Correlation Between Cancer Drug Prices and… Read More
JAMA Network Open Paper Finds “No Relationship” Between Drug Company’s… Read More
Shining a Light on How Big Pharma is Rapidly Increasing Prices on Oncology… Read More
Analysis Highlights How Escalating Prescription Drug Costs, Driven By Big… Read More
Lawmakers Can Highlight Tactics Designed to Block More Affordable Alternatives… Read More